Cryptococcus neoformans Ab:ACnc:Pt:Ser:Qn

Known as: C neoform Ac Ser-aCnc, C neoform Ab Ser-aCnc, Cryptococcus neoformans , Ab:ACnc:Pt:Siero:Qn 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1952-2017
024619522016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
The Cryptococcus neoformans capsular glucuronoxylomannan (GXM) is a potential vaccine antigen that can elicit protective and non… (More)
Is this relevant?
2009
2009
Cryptococcus neoformans is a ubiquitous fungal pathogen which causes human disease ranging from asymptomatic colonization of the… (More)
Is this relevant?
2009
2009
The Cryptococcus neoformans capsular glucuronoxylomannan (GXM) is a potential vaccine antigen that canelicit protective andnon… (More)
  • figure 2
  • figure 3
Is this relevant?
2006
2006
Cell-mediated immune responses to glycoantigens have been largely uncharacterized. Protective T cell responses to the pathogenic… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2005
2005
1. Bei der sogenannten N-Assimilationsprüfung nach dem Benhamschen Platten-Ausstrichverfahren unter Verwendung des Wickerhamschen… (More)
Is this relevant?
2004
2004
Acetolactate synthase catalyses the first common step in isoleucine and valine biosynthesis and is the target of several classes… (More)
Is this relevant?
2004
2004
Received 19 November 2003 Revised 16 January 2004 Accepted 27 January 2004 Acetolactate synthase catalyses the first common step… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1984
1984
 
Is this relevant?
1980
1980
Es wird ein Fluorescenztest zum Nachweis der Kapsel von Cryptococcus neoformans beschrieben, der mit den beiden DNS- und… (More)
  • figure 1
Is this relevant?